跳至主要内容
临床试验/EUCTR2019-000936-24-NO
EUCTR2019-000936-24-NO进行中(未招募)1 期

Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in trauma patients with haemorrhagic shock induced endotheliopathy – a multicentre randomized, placebo-controlled, blinded, investigator-initiated trial - SHINE-TRAUMA

Section for Transfusion Medicine, Capital Region Blood Bank, Copenhagen University Hospital0 个研究点目标入组 220 人开始时间: 2019年10月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age = 18 years
  • Present with clinical signs of hemorrhagic shock (defined by systolic blood pressure <90 mmHg or use of pre-hospital blood transfusion).
  • Activation of internal massive transfusion protocol and initiation of the first transfusion after admission.
  • Randomised within 5 hours of injury and 5 hour of admission to the ED of the participating trial site.
  • Consent is provided on behalf of incapacitated patients by Scientific Guardian
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 140
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 80

排除标准

  • Withdrawal from active therapy
  • Known hypersensitivity to Ilomedin®.
  • Pregnancy (non-pregnancy confirmed by patient having a negative urine- or blood hCG or being postmenopausal defined as females beyond 60 years old or at the investigators discretion)
  • Known severe heart failure (NYHA class IV)
  • Suspected acute coronary syndrome
  • Estimated weight < 40 kg

研究者

发起方
Section for Transfusion Medicine, Capital Region Blood Bank, Copenhagen University Hospital

相似试验

进行中(未招募)
1 期
Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in mechanically ventilated patients with infectious respiratory failureInfectious pulmonary endotheliopathyMedDRA version: 20.0Level: LLTClassification code 10038696Term: Respiratory failure (excl neonatal)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2022-004079-17-DKRigshospitalet450
进行中(未招募)
1 期
Efficacy and safety of 72-hours infusion of prostacyclin (1 ng/kg/min) in patients with septic shock suffering from organ failure caused by endothelial breakdowShock-induced endotheliopathy in patients with septic shockMedDRA version: 23.1Level: PTClassification code 10040070Term: Septic shockSystem Organ Class: 10021881 - Infections and infestations
EUCTR2019-001131-31-DKSection for transfusion Medicines, Capital Region Blood Bank, Copenhagen University Hospital380
招募中
1 期
COMBAT-ARFInfectious pulmonary endotheliopathyMedDRA version: 20.0Level: LLTClassification code: 10038696Term: Respiratory failure (excl neonatal) Class: 10038738
CTIS2024-512641-16-00Rigshospitalet450
进行中(未招募)
1 期
Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in trauma patients with haemorrhagic shock suffering from organ failure caused by endothelial breakdow
EUCTR2019-000936-24-DKSection for Transfusion Medicine, Capital Region Blood Bank, Copenhagen University Hospital220
进行中(未招募)
1 期
Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in patients with COVID-19 induced respiratory failure – a multicentre randomized, placebo-controlled, blinded, investigator-initiated trialCOVID-19 induced respiratory failureMedDRA version: 20.0Level: LLTClassification code 10038696Term: Respiratory failure (excl neonatal)System Organ Class: 100000004855MedDRA version: 20.0Level: LLTClassification code 10040050Term: Sepsis NOSSystem Organ Class: 100000004862
EUCTR2020-001296-33-DKSection for Transfusion Medicine, Capital Region Blood bank, Copenhagen University Hospital80